DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR DETERMINATION OF HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL AND THEIR RELATED SUBSTANCES IN COMBINED TABLET DOSAGE FORM [PDF]
, 2014 Objective: Development of RP-HPLC method for determination of Hydrochlorothiazide (HCTZ), Olmesartan medoxomil (OLM) and their related substances in combined tablet dosage form and validation of the developed method. Methods: Gradient mobile phase system
Chokshi, Avani B. +2 more
core
Vascular Health and Risk Management, 2008 Luis M RuilopeUnidad de Hipertensión, Hospital 12 de Octubre, Madrid, SpainAbstract: Hypertension is a major risk factor for cardiovascular disease that contributes to the premature death of millions of people each year, and identification and ...
Luis M Ruilope
doaj
The Journal of Clinical Hypertension, Volume 26, Issue 1, Page 1-3, January 2024.
wiley +1 more source
The Clinical Efficacy of Clopidogrel Bisulfate Tablets Combined with Olmesartan Medoxomil for Ischemic Stroke with Hypertension and the Effect of Angiotensin II Type 1 Receptor Level on Prognosis. [PDF]
Comput Math Methods Med, 2021 Yu J +6 more
europepmc +1 more source
DEVELOPEMENT AND VALIDATION OF ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF CILNIDIPINE AND OLMESARTAN MEDOXOMIL IN BULK AND TABLET DOSAGE FORM BY RP-HPLC [PDF]
, 2014 An economical, precise, rapid and accurate RP HPLC method has been developed for the simultaneous estimation of Olmesartan Medoxomil and Cilnidipine in bulk and tablet dosage form. Separation was carried out on Jasco HPLC system equipped with HiQ sil C18
Dole, Manjusha N. +2 more
core +1 more source
SIMULTANEOUS DETERMINATION OF ATORVASTATIN CALCIUM AND OLMESARTAN MEDOXOMIL IN RAT PLASMA BY LIQUID CHROMATOGRAPHY ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY AND ITS APPLICATION TO PHARMACOKINETICS IN RATS [PDF]
, 2014 Objective: A novel LC-ESI-MS/MS method was developed and validated for simultaneous determination of atorvastatin calcium (ATR) and olmesartan medoxomil (OLM) in rat plasma and evaluated pharmacokinetic study in rats. Methods: The analytes were separated
Deme, Pragney +2 more
core +1 more source
Российский кардиологический журнал, 2010 The VIOS (Vascular Improvement with Olmesartan medoxomil Study) study is a randomized, parallel study to determine the relative effects of suppressing the renin-angiotensin system (RAS) with the angiotensin receptor antagonist olmesartan medoxomil versus
Ronald D. Smith +6 more
doaj
Кардиоваскулярная терапия и профилактика, 1970 Background: Experimental studies revealed pro-inflammatory properties of angiotensin II. We evaluated antiinflammatory effects of the angiotensin II subtype 1 receptor antagonist olmesartan medoxomil alone and in cotherapy with the HMG-CoA reductase ...
Danilo Fliser +2 more
doaj
Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action. [PDF]
Adv Pharm Bull, 2020 Arun JK +3 more
europepmc +1 more source
Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study [PDF]
, 2013 core +1 more source